Diagnostic News and Research

RSS

Visage 7 PACS solution to be installed at all Lake Imaging sites

Visage Imaging® Inc., a wholly owned subsidiary of Pro Medicus Ltd. announced today a signed deal to provide Lake Imaging, one of Australia's largest independent diagnostic imaging groups, with Visage 7 - its next generation, thin client streaming digital imaging technology (PACS) solution.

23 Nov 2009

Mutated IDH1 gene has novel enzyme activity consistent with cancer-causing gene: Study

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough discovery shows that the mutated form of IDH1 produces a metabolite, 2-hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas, the most common type of brain cancers.

23 Nov 2009

STD infections continue to rise among young people

Sexually spread diseases continue to rise, with reported chlamydia cases setting yet another record in 2008, officials at the Centers for Disease Control recently reported. The CDC estimates that approximately 19 million new STD infections occur each year. Approximately half of them occur in young people between 15 to 24 years of age.

23 Nov 2009

EraGen Biosciences to have access to Illumina’s BeadXpress platform

EraGen Biosciences Inc., a developer of novel molecular reagents for the in-vitro diagnostics (IVD) market, and Illumina Inc., a global company that develops, manufactures and markets integrated systems for analysis of genetic variation and biological function, today announced the formation of a strategic partnership and the execution of non-exclusive licensing agreements.

From Illumina, Inc. 23 Nov 2009

Children exposed to lead and tobacco are 2.4 times more likely to have ADHD

Children exposed prenatally to tobacco smoke and during childhood to lead face a particularly high risk for ADHD, according to research done at Cincinnati Children's Hospital Medical Center.

23 Nov 2009

Serum progesterone concentration test can aid optimal timing of breast MRI in women with irregular periods

A simple blood test corresponding to the follicular phase (days 3-14) of a normal menstrual cycle can aid in optimal scheduling of breast MRI exams in premenopausal women with irregular cycles - possibly reducing the number of repeat scans and non-diagnostic tests patients experience and providing clearer images on which doctors make their recommendations, according to a study published in the December issue of the American Journal of Roentgenology.

21 Nov 2009

Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October: Quest Diagnostics

Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services.

From Quest Diagnostics 21 Nov 2009

Genetic sonogram improves accuracy of noninvasive prenatal screening and detection of Down syndrome

The addition of a "genetic sonogram" maximizes the accuracy of non-invasive testing for Down syndrome, said a Baylor College of Medicine researcher who was lead author of a landmark study in the current issue of Obstetrics and Gynecology.

21 Nov 2009

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

20 Nov 2009

FISH technology accurate in measuring the HER-2 receptor in human breast tumors

The debate on how to select patients who will respond best to costly drug treatments for aggressive breast cancer now favors fluorescence in situ hybridization (FISH) to measure the HER-2 receptor found in human breast tumors, according to a leading pathologist presenting at the Association for Molecular Pathology annual meeting.

20 Nov 2009

Quest Diagnostics announces final results of its cash tender offer

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 and any and all of its 7.50% Senior Notes due 2011 (collectively, the "Notes").

From Quest Diagnostics 20 Nov 2009

BD acquires HandyLab for $275 million

BD today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.

From BD (Becton, Dickinson and Company) 20 Nov 2009

2nd EMUC Meeting to discuss urological cancer

Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next level.

20 Nov 2009

New research studies seek to improve diagnosis and treatment for emphysema and other lung diseases

The University of Michigan Health System will try to find out, through two new multi-center research studies that seek to improve diagnosis and treatment for millions of people affected by emphysema, chronic bronchitis and other lung diseases. Together, those conditions are known as chronic obstructive pulmonary disease (COPD). Both studies are now accepting new participants.

20 Nov 2009

Aware to introduce its new AccuRad ImageShare Platform at the 2009 RSNA meeting

Aware, Inc., a global provider of imaging and biometrics software, today announced it will showcase its new AccuRad ImageShare Platform, a standards-based cross-enterprise image sharing platform for health information exchange (HIE), at the RSNA 2009 Scientific Assembly and Annual Meeting.

19 Nov 2009

AcroMetrix introduces the OptiQual HPV Genotype Panel

AcroMetrix, a leading manufacturer of quality control material for clinical diagnostic and blood testing laboratories, announced today the launch of its OptiQual HPV Genotype Panel. Designed to help clinical laboratories comply with CLIA guidelines for qualitative molecular assays that detect Human Papillomavirus (HPV), this addition to AcroMetrix’s line of women’s health products can assist laboratorians with the validation and verification of their molecular HPV tests.

19 Nov 2009

Vicor Technologies' PD2i nonlinear algorithm and software: a promising diagnostic for in-field trauma triage

David H. Fater, CEO of Vicor Technologies, Inc., today announced that Andriy Batchinsky, MD, a researcher with the U.S. Army Institute of Surgical Research (USAISR), identified Vicor's proprietary PD2i® nonlinear algorithm and software as the most promising diagnostic for in-field trauma triage during a presentation before several hundred attendees at the American Heart Association's Resuscitation Science Symposium 2009 on November 14, 2009 in Orlando, Florida.

19 Nov 2009

WaferGen Biosystems launches new SmartChip Service for gene-expression profiling of thousands of genes

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced a new, innovative service for gene-expression profiling of thousands of genes using the SmartChip(TM) Real-Time PCR System. By taking advantage of the SmartChip Real-Time PCR system, WaferGen will offer universities, pharmaceutical and diagnostic companies a service that utilizes pathway-specific gene panels to discover and validate new biomarkers.

19 Nov 2009

Emerging trends fuelling the US market for reprocessed electrophysiology diagnostic catheters

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the US market for reprocessed electrophysiology diagnostic catheters will grow at a rate of over 15% through 2014. MRG's new US Markets for Electrophysiology Mapping and Ablation Devices 2010 report finds that although reprocessed catheters have existed for a number of years, it is only recently that this device type has begun to play a larger role in the electrophysiology diagnostic market.

19 Nov 2009

DxNA announces successfull evaluation of its GeneSTAT PCR system

DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.

19 Nov 2009

Diagnostic News and Research

Visage 7 PACS solution to be installed at all Lake Imaging sites

Mutated IDH1 gene has novel enzyme activity consistent with cancer-causing gene: Study

STD infections continue to rise among young people

EraGen Biosciences to have access to Illumina’s BeadXpress platform

Children exposed to lead and tobacco are 2.4 times more likely to have ADHD

Serum progesterone concentration test can aid optimal timing of breast MRI in women with irregular periods

Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October: Quest Diagnostics

Genetic sonogram improves accuracy of noninvasive prenatal screening and detection of Down syndrome

FDA approves sNDA for pediatric autism drug ABILIFY

FISH technology accurate in measuring the HER-2 receptor in human breast tumors

Quest Diagnostics announces final results of its cash tender offer

BD acquires HandyLab for $275 million

2nd EMUC Meeting to discuss urological cancer

New research studies seek to improve diagnosis and treatment for emphysema and other lung diseases

Aware to introduce its new AccuRad ImageShare Platform at the 2009 RSNA meeting

AcroMetrix introduces the OptiQual HPV Genotype Panel

Vicor Technologies' PD2i nonlinear algorithm and software: a promising diagnostic for in-field trauma triage

WaferGen Biosystems launches new SmartChip Service for gene-expression profiling of thousands of genes

Emerging trends fuelling the US market for reprocessed electrophysiology diagnostic catheters

DxNA announces successfull evaluation of its GeneSTAT PCR system

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News